Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousStem CellsLymphomaTransplantation ConditioningLymphoma, Non-HodgkinGraft vs Host DiseaseHematopoietic Stem Cell MobilizationHematologic NeoplasmsCord Blood Stem Cell TransplantationHematopoietic Stem CellsBone Marrow TransplantationGranulocyte Colony-Stimulating FactorCombined Modality TherapyTreatment OutcomeMelphalanLeukapheresisCyclophosphamideAntigens, CD34Graft SurvivalAntineoplastic Combined Chemotherapy ProtocolsLymphoma, B-CellHodgkin DiseaseTransplantation ChimeraBusulfanEmbryonic Stem CellsMultiple MyelomaRecurrenceMyeloablative AgonistsRemission InductionLymphoma, FollicularTissue DonorsLymphoma, T-CellAdult Stem CellsBlood Component RemovalMesenchymal Stem Cell TransplantationLymphoma, Large B-Cell, DiffuseVincristineWhole-Body IrradiationDisease-Free SurvivalLiver TransplantationRetrospective StudiesLeukemiaEtoposideHistocompatibilityHistocompatibility TestingPluripotent Stem CellsSurvival AnalysisSurvival RateSalvage TherapyAntineoplastic Agents, AlkylatingImmunosuppressive AgentsVidarabineHematopoiesisCell DifferentiationStem Cell NicheTime FactorsPrednisoneNeural Stem CellsGraft vs Leukemia EffectAntibodies, Monoclonal, Murine-DerivedThiotepaInfectionCytarabineDoxorubicinCell TransplantationTransplantation, IsogeneicInduced Pluripotent Stem CellsLeukemia, Myeloid, AcuteHematologic DiseasesKidney TransplantationPOEMS SyndromeMesenchymal Stromal CellsFollow-Up StudiesAmyloidosisPrognosisCarmustineMultipotent Stem CellsBurkitt LymphomaMyelodysplastic SyndromesBlood CellsStem Cell FactorAntineoplastic AgentsIfosfamideBone MarrowFetal BloodFatal OutcomeLymphoma, Mantle-CellLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell LineageAnemia, AplasticCytomegalovirus InfectionsHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaFlow CytometryBone Marrow CellsNeoplasm, Residual